TickerFactsScreenerDevelopers

NORTHWEST BIOTHERAPEUTICS INC (NWBO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$6.38M2011: -$14.71M2012: -$22.75M2013: -$37.80M2014: -$54.58M2015: -$78.61M2016: -$55.65M2017: -$36.49M2018: -$34.59M2019: -$31.86M2020: -$32.09M2021: -$38.30M2022: -$52.77M2023: -$53.64M2024: -$57.02M2025: -$44.76M-$44.76M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$44.76M+21.5%
2024-$57.02M-6.3%
2023-$53.64M-1.6%
2022-$52.77M-37.8%
2021-$38.30M-19.3%
2020-$32.09M-0.7%
2019-$31.86M+7.9%
2018-$34.59M+5.2%
2017-$36.49M+34.4%
2016-$55.65M+29.2%
2015-$78.61M-44.0%
2014-$54.58M-44.4%
2013-$37.80M-66.1%
2012-$22.75M-54.7%
2011-$14.71M-130.7%
2010-$6.38M—